Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study
帕金森病患者持续皮下注射左旋多巴/磷酸卡比多巴:一项为期12个月的单臂、开放标签3期研究的安全性和有效性结果
期刊:Neurology and Therapy
影响因子:4.8
doi:10.1007/s40120-023-00533-1
Aldred, Jason; Freire-Alvarez, Eric; Amelin, Alexander V; Antonini, Angelo; Bergmans, Bruno; Bergquist, Filip; Bouchard, Manon; Budur, Kumar; Carroll, Camille; Chaudhuri, K Ray; Criswell, Susan R; Danielsen, Erik H; Gandor, Florin; Jia, Jia; Kimber, Thomas E; Mochizuki, Hideki; Robieson, Weining Z; Spiegel, Amy M; Standaert, David G; Talapala, Saritha; Facheris, Maurizio F; Fung, Victor S C